Targeting therapy for inflammatory diseases by anti-TNFα biologics

Yakugaku Zasshi

Volumn 129, Issue 1, 2009, Pages 19-24

  Sugita, Takahisa ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Inflammatory disease; Infliximab; Rheumatoid arthritis; Tumor necrosis factor alpha (anti TNF ) antibody; Tumor necrosis factor alpha (TNF )

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANKYLOSING SPONDYLITIS; BEHCET DISEASE; CROHN DISEASE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EYE INFLAMMATION; HUMAN; INFLAMMATORY DISEASE; INJECTION SITE REACTION; JOINT CAVITY; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE; UVEORETINITIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; BEHCET SYNDROME; CLINICAL TRIALS AS TOPIC; CROHN DISEASE; DRUG DESIGN; HUMANS; INFLAMMATION; RETINITIS; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS;

EID: 58149510618     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.129.19     Document Type: Review

References (16)

1. Brennan F. M., Chantry D., Jackson A., Maini R., Feldmann M., Lancet, 29, 244-247 (1989).
2. Keffer J., Probert L., Cazlaris H., Georgopoulos S., Kaslaris E., Kioussis D., Kollias G., EMBO J., 10, 4025-4031 (1991).
3. Maini R., St Clair E. W., Breedveld F., Furst D., Kalden J., Weisman M., Smolen J., Emery P., Harriman G., Feldmann M., Lipsky P., Lancet, 354, 1932-1939 (1999).
4. Lipsky P. E., van der Heijde D. M., St Clair E.W., Furst D. E., Breedveld F.C., Kalden J. R., Smolen J. S., Weisman M., Emery P., Feldmann M., Harriman G. R., Maini R. N., N. Engl. J. Med., 343, 1594-1602 (2000).
5. Wolfe F., Sharp J. T., Arthritis Rheum., 41, 1571-1582 (1998).
6. Smolen J. S., Han C., Bala M., Maini R. N., Kalden J. R., van der Heijde D., Breedveld F. C., Furst D. E., Lipsky P. E., Arthritis Rheum., 52, 1020-30 (2005).
7. Takeuchi T., Tatsuki Y., Nogami Y., Ishiguro N., Tanaka Y., Yamanaka H., Kamatani N., Harigai M., Ryu J., Inoue K., Kondo H., Inokuma S., Ochi T., Koike T., Ann. Rheum. Dis., 67, 189-194 (2008).
8. Targan S. R., Hanauer S. B., van Deventer S. J., Mayer L., Present D. H., Braakman T., DeWoody K. L., Schaible T. F., Rutgeerts P. J., N. Engl. J. Med., 337, 1029-1035 (1997).
9. Hanauer S. B., Feagan B. G., Lichtenstein G. R., Mayer L. F., Schreiber S., Colombel J. F., Rachmilewitz D., Wolf D. C., Olson A., Bao W., Rutgeerts P., Lancet, 359, 1541-1549 (2002).
10. Rutgeerts P., Diamond R. H., Bala M., Olson A., Lichtenstein G. R., Bao W., Patel K., Wolf D. C., Safdi M., Colombel J. F., Lashner B., Hanauer S. B., Gastrointest. Endosc., 63, 433-442 (2006).
11. Ettehadi P., Greaves M. W., Wallach D., Aderka D., Camp R. D., Clin. Exp. Immunol., 96, 146-151 (1994).
12. Chaudhari U., Romano P., Mulcahy L. D., Dooley L. T., Baker D. G., Gottlieb A. B., Lancet, 357, 1842-1847 (2001).
13. Antoni C., Krueger G. G., de Vlam K., Birbara C., Beutler A., Guzzo C., Zhou B., Dooley L. T., Kavanaugh A., Ann. Rheum. Dis., 64, 1150-1157 (2005).
14. van der Heijde D., Dijkmans B., Geusens P., Sieper J., DeWoody K., Williamson P., Braun J., Arthritis Rheum., 52, 582-591 (2005).
15. Braun J., Landewé R., Hermann K. G., Han J., Yan S., Williamson P., van der Heijde D., Arthritis Rheum., 54, 1646-1652 (2006).
16. Ohno S., Nakamura S., Hori S., Shimakawa M., Kawashima H., Mochizuki M., Sugita S., Ueno S., Yoshizaki K., Inaba G., J. Rheumatol., 31, 1362-1368 (2004).